
Markus Radosavljevic-Peck
Hepatology
Klagenfurt Am Woerthersee, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 232 publications
Austrian lipid consensus : Interdisciplinary evidence-based recommendations on prevention and treatment of lipid-associated diseases from 15 medical specialist societies
Journal: Wiener klinische Wochenschrift
Published: April 22, 2026
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 05, 2026
Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.
Journal: Journal of hepatology
Published: February 06, 2026
Do We Still Need a BCLC-Intermediate Stage for Hepatocellular Carcinoma-Management?
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 05, 2026
Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.
Journal: The Lancet regional health. Europe
Published: December 15, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Journal for immunotherapy of cancer
Published: August 31, 2025
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG).
Journal: Wiener klinische Wochenschrift
Published: August 25, 2025
Long-term survival benefit of atezolizumab/bevacizumab treatment in unresectable HCC patients.
Journal: Hepatology international
Published: July 27, 2025
Spleen stiffness measurement rules out high-risk varices in patients with chronic portal vein thrombosis without cirrhosis.
Journal: Journal of hepatology
Published: June 11, 2025
An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis.
Journal: Liver cancer
Published: May 02, 2025
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis.
Journal: JHEP reports : innovation in hepatology
Published: December 22, 2024
Development of Liver-Heart Score for Early Detection of Myocardial Contractile Dysfunction in Cirrhosis by Strain Imaging.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 23, 2024
Last Updated: 09/26/2026